Form 4: Collegium Pharmaceutical EVP Colleen Tupper Sells Shares Under 10b5-1 Plan

Colleen Tupper, EVP & Chief Financial Officer of Collegium Pharmaceutical, sold 977 shares of common stock at a weighted average price of $30.0034 on March 14, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 14, 2025, Colleen Tupper, the EVP & Chief Financial Officer of Collegium Pharmaceutical, sold 977 shares of the company's common stock.
• The sale was executed at a weighted average price of $30.0034 per share.
• The transactions occurred within a price range of $30.00 to $30.01.
• The sale was conducted under a Rule 10b5-1 trading plan adopted on August 14, 2024.
• Following the reported transaction, Ms. Tupper still beneficially owns 164,269 shares of Collegium Pharmaceutical.
• The filing indicates that Ms. Tupper has direct ownership of the shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was conducted under a pre-arranged 10b5-1 trading plan. It doesn't necessarily reflect a positive or negative outlook on the company's future.

Industry Context

Executive share sales are a common occurrence and are often viewed in the context of insider sentiment. Sales under a 10b5-1 plan are generally less indicative of current sentiment as they are pre-arranged.

Stakeholder Impact

• The sale of shares by a high-ranking executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates